Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Interest & Investment Income (2018 - 2025)

Immucell (ICCC) has disclosed Interest & Investment Income for 5 consecutive years, with $41468.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income rose 121.93% year-over-year to $41468.0, compared with a TTM value of $145735.0 through Sep 2025, up 158.93%, and an annual FY2023 reading of $96570.0, down 36.92% over the prior year.
  • Interest & Investment Income was $41468.0 for Q3 2025 at Immucell, down from $48113.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $48113.0 in Q2 2025 and bottomed at $9527.0 in Q1 2024.
  • Average Interest & Investment Income over 3 years is $27995.5, with a median of $28077.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income plummeted 76.55% in 2024, then soared 293.29% in 2025.
  • Year by year, Interest & Investment Income stood at $14807.0 in 2023, then grew by 26.19% to $18685.0 in 2024, then soared by 121.93% to $41468.0 in 2025.
  • Business Quant data shows Interest & Investment Income for ICCC at $41468.0 in Q3 2025, $48113.0 in Q2 2025, and $37469.0 in Q1 2025.